Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial.
Kovoor JG, Chow CK, Salam A, Webster R, Shiel L, Nelson MR, Affandi JS, Hay P, Burke M, Figtree GA, Usherwood T, Reid CM, Schlaich MP, Rodgers A, Atkins ER. Kovoor JG, et al. Among authors: usherwood t. J Hum Hypertens. 2024 Jun;38(6):516-522. doi: 10.1038/s41371-024-00915-4. Epub 2024 May 14. J Hum Hypertens. 2024. PMID: 38744907 Free PMC article.
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk.
Liu H, Patel A, Brown A, Eades S, Hayman N, Jan S, Ring I, Stewart G, Tonkin A, Weeramanthri T, Wade V, Rodgers A, Usherwood T, Neal B, Peiris D, Burke H, Reid C, Cass A; Kanyini Vascular Collaboration; Kanyini GAP Study Team. Liu H, et al. Among authors: usherwood t. BMC Public Health. 2010 Aug 5;10:458. doi: 10.1186/1471-2458-10-458. BMC Public Health. 2010. PMID: 20687931 Free PMC article. Clinical Trial.
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial.
Gray MP, Berman Y, Bottà G, Grieve SM, Ho A, Hu J, Hyun K, Ingles J, Jennings G, Kilov G, Levesque JF, Meikle P, Redfern J, Usherwood T, Vernon ST, Nicholls SJ, Figtree GA; PPP-CAD Collaborators. Gray MP, et al. Among authors: usherwood t. Am Heart J. 2023 Oct;264:163-173. doi: 10.1016/j.ahj.2023.06.009. Epub 2023 Jun 25. Am Heart J. 2023. PMID: 37364748 Free article.
Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.
Gnanenthiran SR, Tan I, Atkins ER, Avolio A, Bennett B, Chapman N, Chow CK, Freed R, Gnjidic D, Hespe C, Kaur B, Liu HM, Patel A, Peiris D, Reid CM, Schlaich M, Sharman JE, Stergiou GS, Usherwood T, Gianacas C, Rodgers A, Schutte AE. Gnanenthiran SR, et al. Among authors: usherwood t. Am Heart J. 2023 Nov;265:50-58. doi: 10.1016/j.ahj.2023.07.005. Epub 2023 Jul 20. Am Heart J. 2023. PMID: 37479162 Free article.
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure.
Atkins ER, Chye A, Lung T, Nolde JM, Billot L, Burke M, Chalmers J, Figtree GA, Hay P, Hillis GS, Jansen S, Marschner S, Neal B, Nelson MR, Reid CM, Usherwood T, Schlaich M, Chow CK, Rodgers A. Atkins ER, et al. Among authors: usherwood t. Heart. 2023 Oct 26;109(22):1698-1705. doi: 10.1136/heartjnl-2022-322300. Heart. 2023. PMID: 37553138
Utilisation of Chronic Disease and Mental Health Management Services and Cardioprotective Medication Prescriptions in Primary Care for Patients With Cardiovascular Diseases and Cancer: A Cross-Sectional Study.
Tu Q, Hyun K, Hafiz N, Knight A, Hespe C, Chow CK, Briffa T, Gallagher R, Reid CM, Hare DL, Zwar N, Woodward M, Jan S, Atkins ER, Laba TL, Halcomb E, Hollings M, Singleton A, Usherwood T, Redfern J. Tu Q, et al. Among authors: usherwood t. Heart Lung Circ. 2024 May;33(5):738-746. doi: 10.1016/j.hlc.2024.01.030. Epub 2024 Feb 23. Heart Lung Circ. 2024. PMID: 38402036 Free article.
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial.
Wang N, Von Huben A, Marschner S, Nelson MR, Nolde JM, Schlaich MP, Figtree G, Hillis GS, Usherwood T, Reid CM, Chalmers J, Jansen S, Atkins ER, Billot L, Chow C, Rodgers A; QUARTET Investigators. Wang N, et al. Among authors: usherwood t. Hypertension. 2024 May;81(5):1087-1094. doi: 10.1161/HYPERTENSIONAHA.123.22284. Epub 2024 Mar 13. Hypertension. 2024. PMID: 38477128 Clinical Trial.
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
Nolde JM, Atkins E, Marschner S, Hillis GS, Chalmers J, Billiot L, Nelson MR, Reid CM, Hay P, Burke M, Jansen S, Usherwood T, Rodgers A, Chow CK, Schlaich MP. Nolde JM, et al. Among authors: usherwood t. J Hypertens. 2024 Jun 1;42(6):1009-1018. doi: 10.1097/HJH.0000000000003683. Epub 2024 Feb 28. J Hypertens. 2024. PMID: 38501351 Clinical Trial.
Process evaluation of a data-driven quality improvement program within a cluster randomised controlled trial to improve coronary heart disease management in Australian primary care.
Hafiz N, Hyun K, Tu Q, Knight A, Hespe C, Chow CK, Briffa T, Gallagher R, Reid CM, Hare DL, Zwar N, Woodward M, Jan S, Atkins ER, Laba TL, Halcomb E, Johnson T, Manandi D, Usherwood T, Redfern J. Hafiz N, et al. Among authors: usherwood t. PLoS One. 2024 Jun 4;19(6):e0298777. doi: 10.1371/journal.pone.0298777. eCollection 2024. PLoS One. 2024. PMID: 38833486 Free PMC article.
238 results